Monitoring the sensitivity of influenza viruses to oseltamivir, in Romania, from 2016 to 2023
Introduction: influenza is an acute viral disease caused by infection of the upper respiratory tract - difficult to control, which affects a large part of the population. Neuraminidase inhibitors (NAIs), such as oseltamivir and zanamivir, are the antiviral drugs utilized in Romania for the treatment...
Главные авторы: | Mihai Maria Elena, Ivanciuc Alina Elena, Cherciu Carmen Maria, Mihăescu Grigore, Lazăr Mihaela |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
Sciendo
2024-04-01
|
Серии: | Romanian Journal of Laboratory Medicine |
Предметы: | |
Online-ссылка: | https://doi.org/10.2478/rrlm-2024-0010 |
Схожие документы
-
Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
по: Chiara Medaglia, и др.
Опубликовано: (2021-06-01) -
Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus
по: Zhichao Xu, и др.
Опубликовано: (2022-06-01) -
Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023–February 2024
по: Mira C. Patel, и др.
Опубликовано: (2024-07-01) -
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, South Korea
по: Hwajung Yi, и др.
Опубликовано: (2010-12-01) -
Assessment of influenza A (H1N1, H3N2) oseltamivir resistance during 2017-2019 in Iran
по: Amytis Gholami, и др.
Опубликовано: (2022-08-01)